Atlas Trials

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer

Clinical trial NCT00113230 · COMPLETED

Trial details

NCT number
NCT00113230
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2005-02-01
Primary completion
2009-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.